TUMOR-NECROSIS-FACTOR AND INTERFERON AS PROGNOSTIC MARKERS IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION

被引:14
|
作者
HESS, G
ROSSOL, S
ROSSOL, R
BUSCHENFELDE, KHMZ
机构
[1] I. Medizinische Klinik und Poliklinik, Johannes Gutenberg Universität Mainz, Mainz, W-6500
关键词
D O I
10.1007/BF01644475
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Peripheral blood cells were obtained from patients at different stages of their human immunodeficiency virus (HIV) infection. It was found that the capacity to generate interferon alpha was reduced already at Walter Reed stage 2 (WR) while the interferon gamma capacity remained largely unaffected until WR stage 4. Endogenous tumor necrosis factor (TNF) alpha production increased as the HIV disease progressed. The data obtained add to our knowledge on destruction of the immune system by the HIV. Moreover TNF and acid labile interferon alpha might contribute to HIV replication and disease progression. Nevertheless the tests performed are too time-consuming to be introduced into routine analysis of HIV infection or for monitoring its therapy and can so far not be used for intervention strategies. Further studies are needed.
引用
收藏
页码:S93 / S97
页数:5
相关论文
共 50 条
  • [41] HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    EICKHOFF, TC
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (06) : 963 - 973
  • [42] PLEURAL TUBERCULOSIS (PLTB) AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION (HIV)
    RELKIN, F
    SMITH, R
    ARANDA, C
    BERKOWITZ, K
    BHOLA, A
    ROM, W
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A488 - A488
  • [43] RHEUMATOLOGIC MANIFESTATIONS ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
    BRANTUS, JF
    MEUNIER, PJ
    REVUE DU RHUMATISME, 1992, 59 (06): : 428 - 435
  • [45] LIVER-DISEASE AND HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
    SJOGREN, MH
    BRYAN, JP
    MALONE, J
    WAGNER, K
    PERINE, P
    HEPATOLOGY, 1987, 7 (05) : 1155 - 1155
  • [46] HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION IN THE NEWBORN - IMPLICATIONS FOR THE NEONATOLOGIST
    NAGARAJ, A
    KAUL, A
    BHALANI, K
    RAJEGOWDA, BK
    LALA, R
    GROMISCH, DS
    PEDIATRIC RESEARCH, 1987, 21 (04) : A418 - A418
  • [47] EXERCISE AND HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) INFECTION
    LAWLESS, D
    JACKSON, CGR
    GREENLEAF, JE
    SPORTS MEDICINE, 1995, 19 (04) : 235 - 239
  • [48] CARDIAC MANIFESTATIONS OF PEDIATRIC HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
    LIPSHULTZ, SE
    CHANOCK, S
    SANDERS, SP
    COLAN, SD
    PEREZATAYDE, A
    MCINTOSH, K
    CIRCULATION, 1987, 76 (04) : 515 - 515
  • [49] HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION IN PATIENTS ON MAINTENANCE DIALYSIS
    LAGO, M
    PEREZGARCIA, R
    DEVINUESA, MSG
    ANAYA, F
    GOICOECHEA, M
    VALDERRABANO, F
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 579 - 579
  • [50] SUBSTANCES AFFECTING THE INFECTION AND REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)
    YAMAMOTO, N
    HARADA, S
    NAKASHIMA, H
    AIDS RESEARCH, 1986, 2 : S183 - S189